Adherence at baseline and follow-up
| Visual analogue scale . | Baseline . | Follow-up . | Pacross . | ||||
|---|---|---|---|---|---|---|---|
| Range . | M . | SD . | Range . | M . | SD . | ||
| Physician (N=167) | 60-100 | 94.9 | 7.7 | 0-100 | 94.9 | 9.9 | NS |
| Patient (N=169) | 25-100 | 95.3 | 8.5 | 75-100 | 95.7 | 6.1 | NS |
| Family (N=79) | 80-100 | 97.0 | 5.0 | 75-100 | 97.1 | 5.4 | NS |
| Pdown | NS | NS | |||||
| Basel Assessment of Adherence Scale (% of patients [N = 165] who in past 4 weeks) | |||||||
| Dose not taken | 16.1 | 13.3 | NS | ||||
| Consecutive doses not taken | 3.0 | 1.8 | NS | ||||
| Dose taken with >2-h delay | 22.2 | 25.3 | NS | ||||
| Dose reduced | 1.2 | 1.8 | NS | ||||
| % of nonadherent patients | 36.1 | 32.7 | NS | ||||
| % of adherent patients | 63.9 | 67.3 | NS | ||||
| Adherence with scheduled appointments, N = 82* | |||||||
| Adherent patients, % | 89.4 | 86.6 | NS | ||||
| Appointments kept, %, range (M ± SD) | 0-100 (90.9 ± 28.6) | 0-150 (92.1 ± 28.8) | NS | ||||
| Pill count at follow-up, N=162 | Range | M | SD | ||||
| Prescribed dose taken from baseline to follow-up, % | 29-202 | 90.9 | 20.1 | ||||
| Visual analogue scale . | Baseline . | Follow-up . | Pacross . | ||||
|---|---|---|---|---|---|---|---|
| Range . | M . | SD . | Range . | M . | SD . | ||
| Physician (N=167) | 60-100 | 94.9 | 7.7 | 0-100 | 94.9 | 9.9 | NS |
| Patient (N=169) | 25-100 | 95.3 | 8.5 | 75-100 | 95.7 | 6.1 | NS |
| Family (N=79) | 80-100 | 97.0 | 5.0 | 75-100 | 97.1 | 5.4 | NS |
| Pdown | NS | NS | |||||
| Basel Assessment of Adherence Scale (% of patients [N = 165] who in past 4 weeks) | |||||||
| Dose not taken | 16.1 | 13.3 | NS | ||||
| Consecutive doses not taken | 3.0 | 1.8 | NS | ||||
| Dose taken with >2-h delay | 22.2 | 25.3 | NS | ||||
| Dose reduced | 1.2 | 1.8 | NS | ||||
| % of nonadherent patients | 36.1 | 32.7 | NS | ||||
| % of adherent patients | 63.9 | 67.3 | NS | ||||
| Adherence with scheduled appointments, N = 82* | |||||||
| Adherent patients, % | 89.4 | 86.6 | NS | ||||
| Appointments kept, %, range (M ± SD) | 0-100 (90.9 ± 28.6) | 0-150 (92.1 ± 28.8) | NS | ||||
| Pill count at follow-up, N=162 | Range | M | SD | ||||
| Prescribed dose taken from baseline to follow-up, % | 29-202 | 90.9 | 20.1 | ||||
M indicates mean; SD, standard deviation; Pacross, probability of test statistic for test comparing baseline and follow-up; Pdown, probability of test statistic for test comparing within time point; and N, sample size (available observations).
Applies only to patients with scheduled appointments in 30 days prior to baseline and/or follow-up.